Cargando…

Glucose metabolic brain patterns to discriminate amyotrophic lateral sclerosis from Parkinson plus syndromes

BACKGROUND: (18)F-FDG brain PET measures metabolic changes in neurodegenerative disorders and may discriminate between different diseases even at an early stage. The objective of this study was to classify patients with amyotrophic lateral sclerosis (ALS) and Parkinson plus syndromes (PP). To this e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Devrome, Martijn, Van Weehaeghe, Donatienne, De Vocht, Joke, Van Damme, Philip, Van Laere, Koen, Koole, Michel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292827/ https://www.ncbi.nlm.nih.gov/pubmed/30547248 http://dx.doi.org/10.1186/s13550-018-0458-5

Ejemplares similares

Differences in Cerebral Glucose Metabolism in ALS Patients with and without C9orf72 and SOD1 Mutations
por: De Vocht, Joke, et al.
Publicado: (2023)

Multiplex core of the human brain using structural, functional and metabolic connectivity derived from hybrid PET-MR imaging
por: Devrome, Martijn, et al.
Publicado: (2023)

Identifying a glucose metabolic brain pattern in an adeno-associated viral vector based rat model for Parkinson’s disease using (18)F-FDG PET imaging
por: Devrome, Martijn, et al.
Publicado: (2019)

Prognostic relationship of neurofilaments, CHIT1, YKL-40 and MCP-1 in amyotrophic lateral sclerosis
por: Masrori, Pegah, et al.
Publicado: (2022)

Cerebral glucose changes after chemotherapy and their relation to long-term cognitive complaints and fatigue
por: Schroyen, Gwen, et al.
Publicado: (2022)

Long-term Ashtanga yoga practice decreases medial temporal and brainstem glucose metabolism in relation to years of experience
por: van Aalst, June, et al.
Publicado: (2020)

Effect of neurofilament analysis on the diagnostic delay in amyotrophic lateral sclerosis
por: De Schaepdryver, Maxim, et al.
Publicado: (2022)

Use of Multimodal Imaging and Clinical Biomarkers in Presymptomatic Carriers of C9orf72 Repeat Expansion
por: De Vocht, Joke, et al.
Publicado: (2020)

Amyotrophic lateral sclerosis: a clinical review
por: Masrori, P., et al.
Publicado: (2020)

Modelling amyotrophic lateral sclerosis: progress and possibilities
por: Van Damme, Philip, et al.
Publicado: (2017)

Minimally invasive quantification of cerebral P2X7R occupancy using dynamic [(18)F]JNJ-64413739 PET and MRA-driven image derived input function
por: Mertens, Nathalie, et al.
Publicado: (2021)

Mixed response on regorafenib treatment for GIST (gastro-intestinal stromal tumor) according to (18)F–FDG-PET/CT
por: Van Weehaeghe, Donatienne, et al.
Publicado: (2018)

Genetic variability in sporadic amyotrophic lateral sclerosis
por: Van Daele, Sien Hilde, et al.
Publicado: (2023)

Neuroinflammation and Its Association with Cognition, Neuronal Markers and Peripheral Inflammation after Chemotherapy for Breast Cancer
por: Schroyen, Gwen, et al.
Publicado: (2021)

Correction: Schroyen et al. Neuroinflammation and Its Association with Cognition, Neuronal Markers and Peripheral Inflammation after Chemotherapy for Breast Cancer. Cancers 2021, 13, 4198
por: Schroyen, Gwen, et al.
Publicado: (2023)

Brain metabolic changes across King’s stages in amyotrophic lateral sclerosis: a (18)F-2-fluoro-2-deoxy-d-glucose-positron emission tomography study
por: Canosa, Antonio, et al.
Publicado: (2020)

Impaired Structural Motor Connectome in Amyotrophic Lateral Sclerosis
por: Verstraete, Esther, et al.
Publicado: (2011)

Neuroinflammation as potential precursor of leukoencephalopathy in early-stage breast cancer patients: A cross-sectional PET-MRI study
por: Schroyen, Gwen, et al.
Publicado: (2022)

Theoretical discrimination index of postural instability in amyotrophic lateral sclerosis
por: Vallée, Rodolphe, et al.
Publicado: (2022)

Connectome‐Based Propagation Model in Amyotrophic Lateral Sclerosis
por: Meier, Jil M., et al.
Publicado: (2020)

Glucose metabolism in amyotrophic lateral sclerosis: it is bitter-sweet
por: Lerskiatiphanich, Titaya, et al.
Publicado: (2022)

UNC13A in amyotrophic lateral sclerosis: from genetic association to therapeutic target
por: Willemse, Sean W, et al.
Publicado: (2023)

Histone Deacetylase Inhibition Regulates Lipid Homeostasis in a Mouse Model of Amyotrophic Lateral Sclerosis
por: Burg, Thibaut, et al.
Publicado: (2021)

Serotonergic Dysfunction in Amyotrophic Lateral Sclerosis and Parkinson's Disease: Similar Mechanisms, Dissimilar Outcomes
por: Vermeiren, Yannick, et al.
Publicado: (2018)

Genetic Rodent Models of Amyotrophic Lateral Sclerosis
por: Van Den Bosch, L.
Publicado: (2011)

The Effect of Aging on Brain Glucose Metabolic Connectivity Revealed by [(18)F]FDG PET-MR and Individual Brain Networks
por: Mertens, Nathalie, et al.
Publicado: (2022)

The importance of offering early genetic testing in everyone with amyotrophic lateral sclerosis
por: Salmon, Kristiana, et al.
Publicado: (2022)

Clinical validation of the novel HDAC6 radiotracer [(18)F]EKZ-001 in the human brain
por: Koole, Michel, et al.
Publicado: (2020)

Deep learning predictions of survival based on MRI in amyotrophic lateral sclerosis
por: van der Burgh, Hannelore K., et al.
Publicado: (2016)

Beta-2 microglobulin is important for disease progression in a murine model for amyotrophic lateral sclerosis
por: Staats, Kim A., et al.
Publicado: (2013)

Protein aggregation in amyotrophic lateral sclerosis
por: Blokhuis, Anna M., et al.
Publicado: (2013)

Respiratory onset of amyotrophic lateral sclerosis in a pregnant woman with a novel SOD1 mutation
por: Masrori, Pegah, et al.
Publicado: (2022)

Correlation between structural and functional connectivity impairment in amyotrophic lateral sclerosis
por: Schmidt, Ruben, et al.
Publicado: (2014)

Tauroursodeoxycholic acid in patients with amyotrophic lateral sclerosis: The TUDCA-ALS trial protocol
por: Albanese, Alberto, et al.
Publicado: (2022)

Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)

RNA-Binding Proteins in Amyotrophic Lateral Sclerosis
por: Zhao, Melody, et al.
Publicado: (2018)

The impact of age on genetic testing decisions in amyotrophic lateral sclerosis
por: Mehta, Puja R, et al.
Publicado: (2022)

Multimodal longitudinal study of structural brain involvement in amyotrophic lateral sclerosis
por: van der Burgh, Hannelore K., et al.
Publicado: (2020)

Reduction of ephrin-A5 aggravates disease progression in amyotrophic lateral sclerosis
por: Rué, Laura, et al.
Publicado: (2019)

Innovating Clinical Trials for Amyotrophic Lateral Sclerosis: Challenging the Established Order
por: van Eijk, Ruben P.A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gq083khabk86tlb9f4t3or7tog